Introduction

In 2015, a global consensus solidified around the goal of ending AIDS as a public health threat by 2030.  Major tools in achieving these goals are attaining global HIV testing, treatment, and viral suppression targets articulated in the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 targets, which call for ensuring that by 2020: 

  • 90% of people living with HIV will know their status; 
  • 90% of those who know their HIV-positive status will be on antiretroviral therapy (ART); and 
  • 90% of those on ART will achieve virologic suppression.

These goals and the clinical and public health consensus around them are based on two clinical concepts that by the end of 2015 had achieved universally accepted clinical validation. These concepts are treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP). TasP is the idea that HIV-positive persons whose virus is suppressed on ART are extremely unlikely to transmit HIV to sex and drug partners. PrEP is the use of ART by uninfected individuals to prevent HIV infection from sexual contact with an HIV-infected partner. Both of these concepts have been clinically validated in a number of large, randomized, controlled clinical trials. 

TasP and PreP, then, join HIV testing as the three clinical pillars supporting current strategies to curb and eventually eliminate HIV and AIDS. Behavioral, clinical, and structural interventions to expand the use of PrEP and the achievement of TasP (that is, increasing the proportion of HIV-positive persons who are in care, on ART, and with virologic suppression) are integral to achieving the globally accepted goal of ending the epidemic in the next two decades. 

This CME-accredited activity addresses these interventions within the context of:

  • Optimizing the HIV care continuum
  • Testing and linkage to care as gateways to successful HIV control
  • Scaling up ART as both treatment and prevention
  • Strengthening health systems
  • Ending stigma and discrimination
  • Leveraging antiretroviral chemoprophylaxis
  • Placing PrEP in perspective: ethical, sociological, and community views
  • Recent HIV treatment and prevention guidelines
  • The UNAIDS 90-90-90 targets: a smart and doable investment  

Program Overview

This online activity features:

  1. An overview of the 2015 Controlling the HIV Epidemic with Antiretrovirals summit convened by the International Association of Providers of AIDS Care (IAPAC), in partnership with the City of Paris, Joint United Nations Programme on HIV/AIDS (UNAIDS), and AIDS Healthcare Foundation (AHF)
  2. Links to video content from the 2014 Controlling the HIV Epidemic with Antiretrovirals summit, convened by IAPAC, in partnership UNAIDS, Public Health England (PHE), and AHF